DexCom DXCM
$79.32 −$0.87 (-1.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $78.18 -1.44%
Open$80.48
Prev close$80.19
Day range$78.75 – $81.58
Volume4.61M
Market cap$29.58B
P/E (TTM)31.2
Dividend yield–
Earnings
Average move on report day±10.2%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+19.4%
Worst reaction-40.7%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 29 Oct 2026 | After Market | ±9.4% | +2.95% | Within range |
| 2026/Q2 | 30 Jul 2026 | After Market | ±9.5% | +11.95% | Bigger than priced |
| 2026/Q1 | 30 Apr 2026 | After Market | ±10.8% | +3.02% | Within range |
| 2025/Q4 | 12 Feb 2026 | After Market | ±11.6% | +7.59% | Within range |
| 2025/Q3 | 30 Oct 2025 | After Market | ±16.0% | -14.63% | Within range |
| 2025/Q2 | 30 Jul 2025 | After Market | ±9.8% | -9.31% | Within range |
| 2025/Q1 | 1 May 2025 | After Market | ±11.6% | +16.17% | Bigger than priced |
| 2024/Q4 | 13 Feb 2025 | After Market | ±10.3% | +5.92% | Within range |
| 2024/Q3 | 24 Oct 2024 | After Market | ±13.5% | -1.88% | Within range |
| 2024/Q2 | 25 Jul 2024 | After Market | ±12.1% | -40.66% | Bigger than priced |
| 2023/Q4 | 8 Feb 2024 | After Market | ±8.3% | -5.18% | Within range |
| 2023/Q3 | 26 Oct 2023 | After Market | ±14.7% | +10.11% | Within range |
| 2023/Q2 | 27 Jul 2023 | After Market | ±9.6% | +2.33% | Within range |
| 2023/Q1 | 27 Apr 2023 | After Market | ±10.2% | -1.81% | Within range |
| 2022/Q4 | 9 Feb 2023 | After Market | ±9.9% | +9.93% | Bigger than priced |
| 2022/Q3 | 27 Oct 2022 | After Market | ±13.2% | +19.38% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.34B+11.2% YoY
Operating profit$327.20M+34.9% YoY
Net profit$275.10M-3.1% YoY
Diluted EPS$0.72+2.9% YoY
Free cash flow$906.20M+2.4% YoY
Operating cash flow$1.12B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin63.4%
Operating margin24.0%
Net margin19.4%
Return on equity37.7%
Return on assets14.4%
Return on invested capital20.4%
Current ratio1.74
Liabilities / assets59.4%
Cash & investments$1.82B
Total debt$1.37B
Net cash (debt)$445.70M
Free cash flow / sales33.9%
No comments yet — be the first to weigh in on DXCM.
Sign in to join the discussion.